Category: Companion Diagnostics
Global Companion Diagnostics
-
Global Precision Medicine Market Size study & Forecast, by Technology ( Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics and Other Technologies) by Application ( Oncology, CNS, Immunology, Respiratory and Other Applications), and Regional Analysis, 2022-2029
... Regional Analysis, 2022-2029 Global Precision Medicine Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Precision ... Read More
-
Global Next Generation Cancer Diagnostic Market Size study & Forecast, by Technology ( Next-Generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays) by Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), by Function(Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis) and Regional Analysis, 2022-2029
... Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), by Function(Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis) and Regional Analysis, 2022-2029 Global Next ... Read More
-
Global Companion Diagnostics Market Size study & Forecast, by Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing and Other Technologies) by Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma and Other Indications), By End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs and Others)and Regional Analysis, 2022-2029
... Leukemia, Melanoma and Other Indications), By End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, CROs and Others)and Regional Analysis, 2022-2029 Global Companion Diagnostics Market is valued at approximately USD 6.80 billion in 2021 and is ... Read More
-
Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (DX)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (DX)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic ... Read More
-
Companion Diagnostics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product & Service (Assays, Kits & Reagents, Software & Services); By Technology (Polymerase Chain Reaction, Next-generation Sequencing, In-Situ Hybridization, Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA))
... Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa ... Read More
-
Companion Diagnostics Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... in the market, as it could help find the proper treatment for patients affected by the disease. The most commonly used and reliable test for the diagnosis of COVID-19 was the polymerase chain reaction (PCR) ... Read More
-
2023 Global Forecast for Companion Diagnostics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales (product ... Read More
-
2023 Global Forecast for Companion Animal Diagnostics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales ... Read More
-
Global Fluorescent in Situ Hybridization (FISH) Probe Market: Analysis By Product (Instrument/ Software And Consumables), By Technology (Q FISH, Flow FISH And Others), By End User (Clinical Procedures, Research And Companion Diagnostics), By Application (Cancer Diagnostics And Other), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2027
... Diagnostics And Other), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2027 The global fluorescent in situ hybridization (FISH) probe market in 2021 was valued at US$1.40 billion. The market ... Read More
-
Cancer Diagnostics Oncology Companion Diagnostics Market Research Report 2022-2030
... growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Cancer Diagnostics Oncology Companion ... Read More
-
In Situ Hybridization Market by Products (Consumables, Instruments, Software), Technology (DNA FISH, RNA FISH, PNA FISH, CISH), Application (Cancer, Immunology, Neuroscience, Cytology), End User (Hospitals, Pharma, Biotech, CROs) – Global Forecast to 2027
... in situ hybridization market is projected to reach USD 2.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 12.6% during the forecast period. Companion diagnostic products showcase a significant potential ... Read More
-
Companion Diagnostics for Oncology Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
... change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Companion Diagnostics for Oncology market size is growing at a ... Read More
-
Companion Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
... 11.7 Billion by 2027, exhibiting a growth rate (CAGR) of 14.78% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of ... Read More
-
Global Companion Diagnostics Market 2022-2028
... fueling the global market’s growth include a surge in medication reaction incidence, increasing cancer cases, and the growing use of precision medicines. Additionally, the ongoing research and investments in next generation gene-sequencing are expected to ... Read More
-
The Worldwide Market for In Vitro Diagnostic Tests, 15th Edition
... state of IVD and its future is a vital part of making well-informed decisions. The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights ... Read More
-
Global Oncology Companion Diagnostics Market 2022-2028
... 13.6% during 2022-2028. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global oncology companion diagnostics market. It offers an exclusive insight into various details such ... Read More
-
Global Companion Diagnostics Market Forecast 2022-2030
... rising number of cancer cases and mortalities, the increasing number of adverse drug reaction cases, and the growing popularity of precision medicines. MARKET INSIGHTS Companion diagnostics provide crucial data for patient classification, facilitating the effective ... Read More
-
Precision Medicine Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
... and senior management with the critical information they need to assess the global precision medicine market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Companion Diagnostics Market Analysis and Forecast to 2031: By Product & Services (Assays, Kits & Reagents, Software & Services), Technology (Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry, Others), Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases, Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others), and Region
... Diseases, Infectious Diseases, Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others), and Region The global companion diagnostics market was valued at USD 5.9 billion in 2021 and it is anticipated ... Read More
-
Global Oncology Companion Diagnostics Market - 2022-2029
... at a CAGR of XX % during the forecast period (2022-2029). A test that determines whether a patient is a good candidate for a particular drug or therapy. A companion diagnostic test, for instance, could ... Read More
-
The 2023-2028 World Outlook for Oncology Companion Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Companion Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Companion Animal Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Companion Diagnostics Assay Kits and Reagents
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2023-2028 World Outlook for Tissue Diagnostic Devices
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
